On August 29, 2023, the World Health Organization's (WHO) C-TAP (COVID-19 Technology Access Pool) and the United Nations' Medicines Patent Pool (MPP) jointly announced that Medigen Vaccine Biologics Corporation license the COVID-19 vaccine technology to MPP/C-TAP. In the future, if further licenses are granted to third parties, MVC can charge reasonable and affordable royalty fees to facilitate the widespread global application of vaccine manufacturing technology. Date of occurrence of the event: August 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.3 TWD | +2.36% | +8.69% | -19.69% |
06-13 | Medigen Vaccine Biologics Corporation Announces General Manager | CI |
06-13 | Medigen Vaccine Biologics Corporation Announces Audit Committee and Remuneration Committee Member Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.69% | 556M | |
+1.92% | 95.18B | |
-0.13% | 37.55B | |
-10.43% | 33.75B | |
+77.76% | 28.2B | |
-14.82% | 15.63B | |
-3.06% | 13.63B | |
-12.76% | 11.5B | |
+181.73% | 10.81B | |
-53.92% | 9.23B |
- Stock Market
- Equities
- 6547 Stock
- News Medigen Vaccine Biologics Corporation
- Medigen Vaccine Biologics Corporation Provides License Covid-19 Vaccine to WHO C-TAP and UN Medicines Patent Pool